Laddar...
Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases
Since 3-n-butylphthalide (NBP) was approved by the China Food and Drug Administration for the treatment of acute ischemia stroke in 2002, a number of studies have investigated NBP worldwide. In recent years, NBP has also demonstrated potential as treatment of several neurodegenerative diseases, whic...
Sparad:
| I publikationen: | Biomed Rep |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6873419/ https://ncbi.nlm.nih.gov/pubmed/31798868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2019.1246 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|